Radiofrequency catheter ablation remains the primary treatment for ventricular tachycardia, though clinical data on optimal ablation metrics and personalized strategies remain limited.
This review highlights the limited clinical evidence for various VT ablation techniques and emphasizes the need for personalized, metric-driven ablation strategies.
Catheter ablation is the primary treatment for ventricular tachycardia (VT) in patients with structural heart disease. Unfortunately, its long-term success remains limited. Although mapping techniques have advanced considerably, optimal ablation indices remain essential but less well defined. This two-part comprehensive review bridges the gap between bench and bedside by evaluating methods, technologies, and VT-specific lesion parameters. Here, in part 1, we critically examined conventional and emerging techniques, including radiofrequency (RF), high-power short-duration ablation, temperature-controlled RF. In the accompanying paper, part 2, we focus on bipolar RF ablation, pulsed field ablation and ultra-low-temperature cryoablation, venous ethanol and needle ablation. Despite the growing set of tools available for VT operators, clinical data on the practical and safe creation of lesions remain scarce. The evidence supporting most of the techniques reviewed is limited. We emphasise the need for personalised ablation strategies based on substrate and myocardial anatomy and advocate for the development of future integrated, metric-driven technologies.
Niespialowska-Steuden et al. (Wed,) conducted a review in Ventricular tachycardia. Radiofrequency catheter ablation was evaluated. Radiofrequency catheter ablation remains the primary treatment for ventricular tachycardia, though clinical data on optimal ablation metrics and personalized strategies remain limited.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: